Stomach Cancer Trial, Recruiting NCT07078136 Sponsor: Huazhong University of Science and Technology Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07078136
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been found to have a growth beneath the lining of the upper digestive tract (such as the stomach or esophagus), detected by a standard camera examination of the digestive tract (endoscopy), and who have also had a specialised ultrasound examination of that area (called an endoscopic ultrasound, or EUS)
  • People who have received a confirmed tissue diagnosis of a type of digestive tract tumour called a GIST, or another similar growth, through surgery, endoscopic removal, ultrasound-guided sampling, or another biopsy method
  • People whose EUS scan images meet specific technical quality standards, including being taken with certain approved equipment, clearly showing the growth and surrounding tissue, including specific required views, containing no added markings or overlays, and having a minimum image resolution (confirm with trial site)
  • People whose standard endoscopy images clearly show the location, surface features, and edges of the growth, including at least one close-up and one wider view
  • People for whom complete medical records and tissue analysis reports are available

Who may not be able to join:

  • People under 18 years of age
  • People for whom an endoscopic ultrasound examination is medically unsafe, those who have previously had stomach surgery, people who are pregnant, people with serious other health conditions, or people with a known allergy to anaesthetic medications
  • People whose EUS examination could not be completed due to a narrowing or blockage in the esophagus, a large growth causing obstruction, significant changes in heart rate or breathing during the procedure, the person being unable to tolerate the examination, or too much food remaining in the digestive tract
  • People whose EUS images do not meet the required technical quality standards
  • People whose tissue samples do not meet diagnostic requirements — for example, where not enough tissue was collected, where only partial surgical removal was performed (for the GIST group), or where key laboratory staining results are missing from the pathology report (confirm with trial site)
  • People whose tissue results show that the growth has spread from a cancer that started somewhere else in the body

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613986097542

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Huazhong University of Science and Technology
Registry
ClinicalTrials.gov
Start date
28 July 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic accuracy of a multimodal AI model for differentiating gastrointestinal stromal tumors (GISTs) from other upper gastrointestinal mesenchymal tumors; Predictive accuracy of the multimodal AI model for risk stratification of GISTs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov